Overview
Kazuhiko Nakatani practices practicing medicine in Ibaraki, Japan.
Nakatani is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Spinocerebellar Ataxia Type 31, Spinocerebellar Ataxia Type 4, Spinocerebellar Ataxia Type 5, and Myotonic Dystrophy Type 2.
They are actively involved in clinical research, co-authoring 99 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazuhiko Nakatani
Is Kazuhiko Nakatani a top-rated expert for Spinocerebellar Ataxia Type 31?
MediFind is an objective health platform that identifies experts based on real-world data. Kazuhiko Nakatani is classified as an Distinguished expert for Spinocerebellar Ataxia Type 31, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazuhiko Nakatani participate in research or clinical trials?
Yes. Kazuhiko Nakatani has published 99 articles and abstracts on conditions like Spinocerebellar Ataxia Type 31. You can view a list of Kazuhiko Nakatani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Spinocerebellar Ataxia Type 31Nakatani isDistinguished. Learn about Spinocerebellar Ataxia Type 31.
- Advanced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Myotonic DystrophyNakatani isAdvanced. Learn about Myotonic Dystrophy.
- Myotonic Dystrophy Type 2Nakatani isAdvanced. Learn about Myotonic Dystrophy Type 2.
- Paramyotonia CongenitaNakatani isAdvanced. Learn about Paramyotonia Congenita.
- Primary Lateral SclerosisNakatani isAdvanced. Learn about Primary Lateral Sclerosis.
- Spinocerebellar Ataxia Type 4Nakatani isAdvanced. Learn about Spinocerebellar Ataxia Type 4.
- Spinocerebellar Ataxia Type 5Nakatani isAdvanced. Learn about Spinocerebellar Ataxia Type 5.
- Experienced
- DementiaNakatani isExperienced. Learn about Dementia.
- Dentatorubral-Pallidoluysian Atrophy
- Drug Induced DyskinesiaNakatani isExperienced. Learn about Drug Induced Dyskinesia.
- Frontotemporal DementiaNakatani isExperienced. Learn about Frontotemporal Dementia.
- Huntington DiseaseNakatani isExperienced. Learn about Huntington Disease.
- Lafora DiseaseNakatani isExperienced. Learn about Lafora Disease.
- Myoclonic EpilepsyNakatani isExperienced. Learn about Myoclonic Epilepsy.
- Olivopontocerebellar AtrophyNakatani isExperienced. Learn about Olivopontocerebellar Atrophy.
- Spinocerebellar AtaxiaNakatani isExperienced. Learn about Spinocerebellar Ataxia.
- Togaviridae DiseaseNakatani isExperienced. Learn about Togaviridae Disease.